CONNEXIN THERAPEUTICS

connexin-therapeutics-logo

Current estimates suggest a global glaucoma prevalence of over 60 million cases. And, with an aging population, this prevalence is growing rapidly. Most cases are associated with elevated intraocular pressure. However, despite the availability of drugs that reduce intraocular pressure, visual impairment and vision loss remain a problem. While most cases are associated with elevated intraocular pressure, approximately 25% of cases have normal intraocular pressure. Patients are frequently treated with drugs to reduce intraocular pressure, simply because physicians lack therapeutic options At Connexin Therapeutics, they are developing the options ophthalmologists need to preserve vision in their patients with glaucoma and related conditions.

#People #Website #More

CONNEXIN THERAPEUTICS

Industry:
Therapeutics

Founded:
2018-01-01

Address:
Cambridge, Cambridgeshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.connexintx.co.uk

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Apache Wordpress Plugins Google Apps For Business


Current Employees Featured

carlos-n-velez_image

Carlos N. Velez
Carlos N. Velez Chief Executive Officer @ Connexin Therapeutics
Chief Executive Officer
2018-08-01

Official Site Inspections

http://www.connexintx.co.uk

  • Host name: ded3917.inmotionhosting.com
  • IP address: 205.134.255.219
  • Location: Los Angeles United States
  • Latitude: 34.0318
  • Longitude: -118.4252
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90064

Loading ...

More informations about "Connexin Therapeutics" on Search Engine